The Evidence Base®’s Post

A new pioneering project, led by researchers from The University of Edinburgh and University of Dundee, is leveraging AI to predict an individual’s risk of developing dementia through the analysis of brain scans. This initiative, known as the Scottish AI in Neuroimaging to predict Dementia and Neurodegenerative Disease (SCAN-DAN), is part of the broader NEURii collaboration, which seeks to transform neurology and digital sciences into practical healthcare solutions. Read at The Evidence Base® https://lnkd.in/eAWMSK3J

Welcome to the latest weekly update from The Evidence Base® Explore our daily highlights from all three days of the #ISPEAnnual2024 conference. Read our interview with Ashita Batavia, MD, MS (Johnson & Johnson Innovative Medicine) to learn more about the FDA grant award project ‘Development of Novel Methods to Enable Robust Comparison of Real-World Progression Free Survival (rwPFS) and Clinical Trial PFS in Multiple Myeloma’. I share my Editor’s picks from the September issue of the Journal of Comparative Effectiveness Research, including an Editorial on whether there is a need for an international ISPOR—The Professional Society for Health Economics and Outcomes Research value flower and research assessing the #realworldevidence frameworks provided by #regulatory and #HTA agencies. Check out our Guest Column which explores how researchers can improve patient treatments and outcomes by incorporating #SDOH variables into their work. Don't forget to sign up to our #webinars, including: - Introducing the #ROPAD consortium: unlocking real-world genetic insights to accelerate treatment access for Parkinson’s disease, September 24, 10:30am ET (CENTOGENE) - Incorporating patient centric sampling into multi-center clinical trials: Summary of a PCSIG workshop, October 2, 2024, 11:00AM ET - Replacing serum with dried blood microsampling for pediatric pharmacokinetics of prophylactic RSV monoclonal antibody, September 25, 2024, 11:00am ET Plus, #RWE and #RWD news from NICE - National Institute for Health and Care Excellence, OMNY Health and the NHS

OMNY Health has announced the launch of a new GLP-1 data network that integrates real-world data (#RWD) from electronic health record (EHR) data of >645,000 patients. Read more at The Evidence Base® https://lnkd.in/efRChEWP #RealWorldData #GLP1 #HealthData #RealWorldDataNetwork #RWE #RealWorldEvidence

That's a wrap on #ISPEAnnual2024! It's been a great event, bringing together experts from around the globe to discuss key issues in pharmacoepidemiology, real-world evidence, and the mission of the International Society for Pharmacoepidemiology to advance the health of the public.   The final day included a packed schedule, including talks on social determinants of health and the problem of confounding (and how best to tackle it!).   📖 Read our recap of some of the sessions from Day 3 here https://lnkd.in/gKR4HH6a   #AI #ISPE #Pharmacoepidemiology

As part of its #RealWorldEvidence efforts, the FDA announced four new Cooperative Agreement awards in 2023 to explore the use of #RealWorldData for regulatory decision-making. These demonstration projects aim to broaden the FDA’s understanding of #RWD and #RWE in drug approval and post-approval studies and encourage innovative approaches to support the use of RWE while ensuring that scientific evidence meets the agency’s standards.   In this interview, we speak with Ashita Batavia, MD, MS (Johnson & Johnson Innovative Medicine) to learn more about the project ‘Development of Novel Methods to Enable Robust Comparison of Real-World Progression Free Survival (rwPFS) and Clinical Trial PFS in Multiple Myeloma’.   #HealthData #MultipleMyeloma #Myeloma #ProgressionFreeSurvival   Read at The Evidence Base®: https://lnkd.in/eg_jBCgH 

It’s the final day of the International Society for Pharmacoepidemiology Annual Conference, but there’s still lots to look forward to… Recaps of days 1 and 2 are on The Evidence Base now, and be sure to check back soon for Day 3! #ISPEAnnual2024 #ISPE #pharmacoepidemiology

Day 2 of the International Society for Pharmacoepidemiology Annual Meeting 2024 was another jam-packed program of content, which today included a plenary session on perinatal pharmacoepidemiology, a symposium session on implementation science, and, of course, the Annual Awards! 🏆 📖 Read our recap of some of the sessions from Day 2 here https://lnkd.in/e2pM8p9J   #ISPEAnnual2024 #ISPE #Pharmacoepidemiology

Check out our Editor Laura Dormer's picks from the latest issue of the Journal of Comparative Effectiveness Research, including an Editorial on whether there is a need for an international #ISPOR value flower; a Plain Language Summary of Publication article on treatment for narcolepsy type 1 and type 2; and research conducting an environment scan of real-world evidence frameworks. LCP, University of Montpellier, Cytel, Takeda #OpenAccess #PlainLanguage #PLSP #HEOR #RWE https://lnkd.in/ef2UVfv6